<DOC>
<DOCNO>
EP-0011277
</DOCNO>
<TEXT>
<DATE>
19800528
</DATE>
<IPC-CLASSIFICATIONS>
C07D-498/18 C07D-498/00 A61K-31/535 A61P-35/00 
</IPC-CLASSIFICATIONS>
<TITLE>
dechloromaytansinoids, their production and use  and pharmaceutical compositions containing them.
</TITLE>
<APPLICANT>
takeda chemical industries ltdjp<sep>takeda chemical industries, ltd.<sep>takeda chemical industries, ltd. 1-1, doshomachi 4-chomechuo-ku, osakajp <sep>
</APPLICANT>
<INVENTOR>
akimoto hiroshijp<sep>miyashita osamujp<sep>akimoto, hiroshi<sep>miyashita, osamu<sep>akimoto, hiroshihamakoshien-jutaku 3-208 1-6, minamikoshien3-chome nishinomiya hyogo 663jp<sep>miyashita, osamu25-403, 2-wakayamadai 2-chome shimamoto-chomishima-gun osaka, 618jp<sep>
</INVENTOR>
<ABSTRACT>
novel dechloromaytansinoids of the formula:    wherein r is h, or acyl having 1 to 20 carbon atoms, have  antimitotic, antitumor and antimicrobial activities.  
</ABSTRACT>
<DESCRIPTION>
dechloromaytansinoids, their production and used this invention relates to dechloromaytansinoid compound of the formua: emi1.1 wherein r is h or acyl having 1 to 20 carbon atoms, and to methods for production and use of the compounds (i). referring to the above formula (i), the acyl group r is an acyl group derived from a carboxylic acid having a molecular weight of up to about 300. the acyl group thus includes, among others, saturated or unsaturated aliphatic acyl groups, saturated or unsaturated alicyclic acyl groups, aromatic acyl groups, saturated or unsaturated heterocyclic acyl groups and n-acyl-a-amino acid acyl groups these acyl groups may be represented by the following formula: -cor2 (a) wherein r2 is h, alkyl, alkenyl, cycloalkyl, cycloalkenyl, aryl or heterocyclic group, any of which may optionally be substituted, the cyclic groups being attached, directly or through an alkylene chain, to the carboxyl group in the formula (a). among these groups, those having substituents may for instance be n-acyl-&alpha;-aminoacyl groups of the following formula: emi2.1 wherein r) is h, alkyl, cycloalkyl, aryl, indolyl or imidazolyl, any of which groups may optionally be substi tuted, the cyclic groups being attached to the a-carbon atom directly or through an alkylene chain r4 is h, alkyl, cycloalkyl or aryl, any of which groups may optionally be substituted, the cyclic groups being attached to the natom directly or through an alkylene chain; ; ' is h, alkyl, alkenyl, cycloalkyl, cycloalkenyl, aryl or heterocyclic group, any of which groups may optionally be substituted, the cyclic groups being attached to the carbonyl group on the n-atom directly or through the intermediary of an alkylene chain; and r5 may further be alkoxy bornyloxy, isobornyloxy or benzyloxy r2 in the acyl group designated by the above formula (a) will now be described in detail, the alkyl group rê includes, among others, alkyls of about 1 to 18 carbon atoms (e.g. methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl, tert-butyl, pentyl, isopentyl, l-methylpropyl, hexyl, heptyl, 3-heptyl, octyl, nonyl, decyl, undecyl, dodecyl, tridecyl, pentadecyl, heptadecyl) and, preferably, represents an alkyl group of about 1 to 6 carbon atoms the alkenyl group p2 includes, among others, alkenyls of about 2 to 10 carbon atoms (e.g. vinyl, alkyl, 1-methyl vinyl, 2-methyl-vinyl, 1-octenyl, 1-decenyl) and, preferable represents an alkenyl group of about 2 to 4 carbon atoms. the cycloalkyl group r2 includes, for example, cyclo alkyls of about 3 to 10 carbon atoms (e.g. cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooct norbornyl, adamantyl) and, preferably, represents a cyclo- alkyl group of 3 to 7 carbon atoms the cycloalkenyl group r2 includes, for example, cyclic alkenyls of about 3 to 10 carbon atoms (e,g 1-cyclobutenyl 1-, 2- or 3-cyclopentenyl, 1-, 2- or 3-cyclohexenyl, 4-cyclo- heptenyl, 4-cyclooctenyl, 1, 4-cyclohexadienyl, 4-norbornapht 2,4,6-cycloheptatrienyl ) the aryl group r2 may for example be phenyl or napht and preferably is phenyl. the heterocycllc group r2 includes saturated or uz- saturated 4-, 5- or 6-membered heterocyclic groups includ n, o or/and s atoms, to which groups a benzene ring may optionally
</DESCRIPTION>
<CLAIMS>
   snat    is claimed is: 1 a compound of the formula: emi34.1        wherein r is h cr acyl having 1 to 20 carbon atoms.   a compound according to claim 1, wherein r is acyl  of the formula:  -corê  wherein rê is h, c1-18 alkyl, c2-10 alkenyl, c2-10  cycloalkyl, c3-10 cycloalkenyl, phenyl, naphthyl or, 4-,  5- or 6-membered heterocyclic group containing n,   o    or/  and s which may have a fused benzene ring,  any of said groups being unsubstituted or substituted  by c1-4 alkyl, c1-4 alkoky, c2-4 alkanoyl, c2-4 alkanoyl  oxy, c2-4 alkoxycarbonyl, halogen, nitro, cyano, trifluoro  methyl, di-c1-4 alkylamino, c1-4 alkylthio, methylsulfinyl,  methylsulfonyl, oxo, thioxo or c1-4 alkanoylamido, and  said cycloalkyl, cycloalkenyl, phenyl, naphthyl and  heterocyclic groups being attached, directly or through  c1-4 alkylene, to the carbonyl group in the acyl r.      compound    according to claim 1, wherein is n-acyl-    &alpha;-aminoacyl    of the formula:   emi35.1       wherein r3 is h, c1-18 alkyl, c3-10 cycloalkyl, phenyl, naphthyl,  indolyl or imidazolyl, r4 is h, c1-18 alkyl, c3-10 cycloalkyl, phenyl, naphthyl,  and is h, c1-18 alkyl, c2-10 alkenyl, c3-10 cycloalkyl,  phenyl, naphthyl or, 4-,   5-    or 6-membered hetero  cyclic group containing n, 0 or/and s which may have  a fused benzene ring,  any of said groups in r3,   r4    and   r5    being unsubstituted or substituted by   c1,4    alkyl,   c1,4    alkoxy, c2-4 alkanoyl, c2-4 alkanoyloxy, c2-4 alkoxycarbonyl, halogen, nitro, cyano, trifluoromethyl, di-c1-4 alkylamino, c1-4 alkylthio, methylsulfinyl, methylsulfonyl, oxo,  thioxo or c1-4 alkanoylamido, and  said cycloalkyl, cycloalkenyl, phenyl, naphthyl and heterocyclic groups including indolyl and imidazolyl in   r3,    r4 and   r5    being attached, directly or through   c1,4    alkylene, to the a-carbon atom, n-atom or the carbonyl group on the n-atom in the n-acyl-a-aminoacyl   r.        a compound according to claim 2 wherein   r@    is c1-6  alkyl, c3-7 cycloalkyl, phenyl or pyrid  said alkyl, being unsubstituted or substituted by  halogen, and  said cycloakyl, phenyl and pyridyl being attached,  directly or through c1-4 alkylene, to the   @@aroenyl    group  in the acyl r.   5. a compound according to claim 3, wherein r3, r4 and r5  are c1-6 alkyl.   6. the compound according to claim 1, which in dechloro  maytansinol 7. the compound according to claim 1, which in dechloro  maytansine.      8    the compound according to claim 1, which  dechloromaytansine.   the compound according to claim 1, which in dechloro  maytansinol 3-isobutyrate.   10. the compound according to claim 1, which is dechloro  maytansinol   3-nicotinate    11. the compound according to claim 1, which in dechloro  maytansinol 3-cyclohexanecarboxylate.   12. the compound according to claim 1, which in dechloro  maytansinol 3-phenylacetate.    13. the compound according to claim 1, which in dechloro    maytansinol 3-chloroacetate.        14. a pharmaceutical composition which comprises as active ingredient an effective amount of a compound of the formula: emi37.1        wherein r is h or acyl having 1 to 20 carbon atoms,  an   a    pharmaceutically acceptable carrier or diluent  therefor   5 a    use of a compound of the formula: emi37.2        wherein r is h or acyl having 1 to 20 carbon atoms,  for inhibiting the growth of tumor cells and prolonging  the survival time of a tumor-bearing warm blooded  animal 16. a method for producing dechloromaytansinol which  comprises reducing a compound of the formula:   emi38.1          wherein      r1    is acyl having 1 to   2u    ca  metal hydride.    a methode for producing a composition which   @a    emi38.2        wherein r1 is acyl having 1 to 20 ca   @    which comprises reacting   dechloromaytansinol @@n a    carboxylic acid of the formula:  r1-oh wherein r1 is as defined above   or a @@setate derivative    thereof with respect to tis carbon   @.     
</CLAIMS>
</TEXT>
</DOC>
